Leverage Shares 2X Long FIX Daily ETF FIXX
As ofNov 20, 2026, 3:58 PM EST
- YTD
- -69.05%
- 1 year
- -69.05%
5D -0.81 (-14.57%)
- Assets
- $272.80K
- Expense ratio
- 0.99%
- NAV
- 4.96
- Holdings
- 4
- Asset class
- Equity
- Issuer
- LeverageShares
- Inception
- Aug 19, 2026
- YTD return
- -69.05%
- 1-year return
- -69.05%
- Volume
- 9.14K
- Avg volume
- 7.91K
- Open
- 4.57
- Previous close
- 5.07
- Day's range
- 4.25 – 4.45
- 52-week range
- 3.87 – 15.67
- 50-day average
- 13.80
- 200-day average
- 16.10
About Leverage Shares 2X Long FIX Daily ETF
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases in the United States. The company offers proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a nuclease-free gene editing mobility, gene therapy or for various genetic disorders. Its earlier stage product candidates comprising HMI-202, an investigational gene therapy which completed IND-enabling studies for the treatment of metachromatic leukodystrophy; and HMI-104 which completed IND-enabling studies. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- homologymedicines.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on FIXX — it syncs with the Stock Master app.
